Skip to main content

Table 4 BreastMark results for the MammaPrint gene signature for LNN patients using DFS as the survival end point

From: BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome

Entrez Gene ID

Gene symbol

Hazard ratio

P-value

Sample number

MammaPrint correlation with prognosis

Good Prognosis

8659

ALDH4

0.92

0.42

1105

0.421

8817

FGF18

0.86

0.16

1183

0.411

27113

BBC3

0.76

0.03

1004

0.407

57593

KIAA1442

NA

NA

NA

0.402

57758

CEGP1

0.69

5.37e-03

819

0.400

146923

RUNDC1

0.53

2.23e-03

387

0.390

8840

WISP1

0.85

0.13

1183

0.384

2947

GSTM3

0.79

0.02

1183

0.380

151126

ZNF533

0.84

0.39

382

0.375

146760

RTN4RL1

0.84

0.45

281

0.374

10455

PECI

0.81

0.05

1059

0.373

7043

TGFB3

0.83

0.09

1155

0.372

55351

HSA250839

0.71

2.48e-03

1109

0.368

10455

PEC1

0.88

0.05

1059

0.366

58475

CFFM4

0.67

0.01

510

0.364

163

AP2B1

0.84

0.10

1155

0.363

79132

LGP2

0.67

1.70e-03

986

0.363

Poor prognosis

55321

C20orf46

1.09

0.41

1137

-0.356

11082

ESM1

1.41

1.71e-03

1139

-0.357

9134

CCNE2

1.74

2.74e-06

1032

-0.357

54583

EGLN1

1.44

2.13e-03

981

-0.357

1058

CENPA

1.94

1.26e-09

1183

-0.358

9055

PRC1

1.87

1.03e-08

1137

-0.358

445815

AKAP2

1.01

0.95

928

-0.360

10874

NMU

1.51

1.12e-04

1183

-0.360

3488

IGFBP5

1.18

0.12

1155

-0.360

10531

MP1

1.08

0.52

893

-0.361

57110

LOC57110

1.50

2.16e-04

1109

-0.361

3488

IGFBP5

1.19

0.12

1155

-0.361

8577

TMEFF1

1.30

0.02

1077

-0.362

4175

MCM6

1.84

1.56e-08

1183

-0.364

643008

LOC643008

NA

NA

NA

-0.365

83879

CDCA7

1.02

0.93

387

-0.365

5984

RFC4

1.62

6.38e-06

1183

-0.366

23594

ORC6L

1.80

7.32e-08

1137

-0.366

6515

SLC2A3

1.12

0.29

1155

-0.366

57211

DKFZP564D0462

0.96

0.72

1004

-0.367

79791

FBXO31

0.85

0.13

1137

-0.367

1633

DCK

1.36

4.67e-03

1155

-0.368

51514

L2DTL

1.62

1.19e-05

1109

-0.369

1284

COL4A2

1.22

0.10

1004

-0.371

9833

KIAA0175

1.82

2.21e-08

1183

-0.371

92140

MTDH

1.32

0.01

1155

-0.373

51377

UCH37

1.19

0.11

1137

-0.374

51560

RAB6B

0.98

0.84

1109

-0.376

160897

GPR180

1.24

0.31

337

-0.379

79888

FLJ12443

1.31

0.02

1004

-0.381

8293

SERF1A

1.54

0.44

28

-0.383

8476

PK428

1.19

0.10

1183

-0.384

10403

HEC

1.34

7.04e-03

1183

-0.386

8833

GMPS

1.37

3.12e-03

1183

-0.386

1894

ECT2

1.59

1.70e-05

1137

-0.390

4318

MMP9

1.25

0.04

1183

-0.392

5019

OXCT

1.00

0.99

1183

-0.392

2781

GNAZ

1.08

0.49

1155

-0.396

2321

FLT1

1.05

0.71

857

-0.398

2131

EXT1

1.25

0.04

1183

-0.400

56942

DC13

1.80

4.69e-08

1137

-0.400

81624

DIAPH3

1.08

0.52

998

-0.405

81624

DIAPH3

1.08

0.52

998

-0.409

169714

QSOX2

1.57

0.04

343

-0.415

286052

LOC286052

NA

NA

NA

-0.424

51203

LOC51203

1.83

2.44e-08

1137

-0.425

81624

DIAPH3

1.08

0.52

998

-0.433

85453

TSPYL5

0.96

0.72

999

-0.527

  1. DFS, disease-free survival; LNN, lymph node-negative.